Walking Sensation Study for Older Adults

This study is testing if a device called Walkasins can help older adults who have reduced sensation in their feet walk better. Walkasins is a neuroprosthesis (a device that helps nerves work) that provides real-time sensory input by sending vibrations to your lower legs. Researchers want to see if using Walkasins can make walking easier and require less mental effort for people aged 65 to 95. You can join if you are in this age range and don't have certain medical conditions or high blood pressure that would affect walking. Success in this study would mean that people using Walkasins show better walking ability, less mental effort during walking, and more stable walking patterns. The current recruitment status is unclear, and the study plans to enroll 30 participants.

Study design
This is an interventional study with 30 planned participants. It compares an active Walkasins device to an inactive one.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed up for 7 days after the baseline measurements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06975423

Walking Sensation Study

Recruiting
NAAges 65–95InterventionalTreatment
University of Florida
~30 participants
Updated 2026-06-04 on ClinicalTrials.gov
What's tested:Active lower-limb neuroprosthesisInactive lower-limb neuroprosthesis

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Dual-Task Cost
Measured over Baseline, 7-day follow-up
+2 more outcomes measured
Aging
Sensory Deficit
1 sites across 1 states
Florida1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

age 65 - 95.
no severe high blood pressure (systolic \< 180 mmHg and/or diastolic \< 100 mmHg at rest).
no severe vision impairment: visual acuity ≥ 20/70 as determined by Snellen eye chart.
slow walking speed: preferred walking speed slower than 1.0 m/s over 10 meter.
no cognitive impairment: Montreal Cognitive Assessment (MoCA) score ≥ 26 out of 30 possible points.
foot sensory impairment: Inability to feel the 10 g monofilament at ≥1 of 10 tested sites on either foot is considered a sign of impaired protective sensation. loss.
diagnosed neurological disorder or injury of the central nervous system, or observation of symptoms consistent with such a condition (Alzheimer's, Parkinson's, stroke, etc.)
severe arthritis, such as awaiting joint replacement
current cardiovascular, lung or renal disease; untreated diabetes; terminal illness
myocardial infarction or major heart surgery in the previous year
cancer treatment in the past year, except for nonmelanoma skin cancers and cancers having an excellent prognosis (e.g., early stage breast or prostate cancer)
current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
currently taking medications that affect the central nervous system, such as benzodiazepines, anti-cholinergic medication, and GABAergic medication, among others
no severe vision impairment (visual acuity ≥ 20/70 as determined by Snellen eye chart)
uncontrolled hypertension at rest (systolic \> 180 mmHg and/or diastolic \> 100 mmHg)
bone fracture or joint replacement in the previous six months
current enrollment in any other clinical trial
planning to relocate out of the area during the study period
non-English\* speaking, due to the likelihood of difficulties following instructions and communicating remotely
clinical judgment of the investigative team
  • Dual-Task CostBaseline, 7-day follow-up

    Comparison of dual-task walking performance between active and inactive lower-limb neuroprosthesis conditions

  • Gait VariabilityBaseline, 7-day follow-up

    Comparison of gait performance between active and inactive lower-limb neuroprosthesis conditions.

  • Brain ActivityBaseline, 7-day follow-up

    Comparison of prefrontal cortical activity during active versus inactive lower-limb neuroprosthesis conditions.